OPUS B12 CONTROLS— 510(k) K962694

Substantially Equivalent

Behring Diagnostics, Inc.

FDA 510(k) clearance K962694 for OPUS B12 CONTROLS, Substantially Equivalent on 1996-07-22. Applicant: Behring Diagnostics, Inc..

Clearance details

Applicant: Behring Diagnostics, Inc.
Product code: Code JJX
Advisory panel: Clinical Chemistry
Date received: 1996-07-11
Decision date: 1996-07-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Westwood, MA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code JJX

product code JJX

Other: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.